Regulatory Filings

2018

Q1
03/15/2018
Call 2018 Annual General Meeting
02/23/2018
Results presentation 2017
02/23/2018
Dividend 2017
Q2
04/30/2018
I Bayón new chair of Audit Committee
04/23/2018
Cease of France Managing Director
04/20/2018
Results presentation
AGM Agreements 2018
04/20/2018
Q3
23/07/2018
1H18 results presentation
23/07/2018
Dividend against results of 2018
23/07/2018
New Managing Director of Naturhouse Health, S.A.'s subsidiary in France
Q4
10/30/2018
Appointment of new Non-Board Member vicesecretary of the Board of Directors
10/30/2018
Second Interim divident agains 2018 results
10/30/2018
3Q18 Results Presentation

2017

Q1
24/02/2017
2016 final ordinary dividend
24/02/2017
2016 Results Presentation
18/01/2017
Net Openings 2016
Q2
17/07/2017
Resignation general director of Poland
17/07/2017
Composition of the board of directors
4/05/2017
New Managing Director of Naturhouse Health, S.A.'s subsidiary in France
27/04/2017
2017 General Shareholders Meeting 2017. Agreements adopted
Q3
8/1/2017
Chage of registered office
7/28/2017
Rectification of a Material Fact dated on 21 of July 2017
7/21/2017
Dividend against results of 2017
7/21/2017
1H17 Results Presentation
7/21/2017
Changes in Board Committees
Q4
11/21/2017
Rafat Podlaszewski has been appointed as Managing Director of the Polish subsidiary of Naturhouse Health S.A
10/21/2017
3Q17 Results Presentation

2016

Q1
11/16/2016
Ignacio Bayón joins Naturhouse as an independent board member
11/14/2016
Net Openings october 2016
10/31/2016
3Q16 Results presentation
10/31/2016
Internal Code of Conduct
Q2
20 July 2016
net openings 1H16
22 of April 2016
1Q16 results
Q3
09/15/2016
Liquidity Agreement
2016-07-27
Changes in the board of directors
2016-07-27
Dividend against results of 2016
2016-07-27
1H Results Presentation
Q4
11/16/2016
Ignacio Bayón joins Naturhouse as an independent board member
11/14/2016
Net Openings october 2016
10/31/2016
3Q16 Results presentation
10/31/2016
Internal Code of Conduct

2015

Q1
Q2
22-5-2015
NATURHOUSE informs of the exercise of the green shoe call option regarding 1,097,637 shares and transactions carried out during stabilization period
20 of May 2015
Next opening Abril
Q3
27-7-2015
The company submits the agreement adopted by the Board of Directors approving a third interim dividend against 2015 earnings.
07 de julio 2015
New subsidiary company in Lithuania
Q4
18-12-2015
Centers end of November
14-12-2015
Liquidity agreement
4-12-2015
Comunicación sobre la información solicitada a las sociedades cotizadas en relación con determinadas disposiciones de la Ley de Sociedades de Capital que forman parte de las normas de ordenación y disciplina de mercado de valores
4-12-2015
Formulario para la difusión del Estado miembro de origen

Further information from the CNMV .